ADIPOQ and prostate carcinoma: Furthermore, no significant difference was observed in androgen receptor positivity of prostate cancer cells in the adiponectin < 6 and leptin > 4 group compared to the adiponectin > 6 and leptin < 4 group (p = 0.3696, Supplementary Materials, Figure 2).